申请人:Conte Immacolata
公开号:US20080249146A1
公开(公告)日:2008-10-09
The present invention relates to compounds of the formula (I), wherein R
1
, R
2
, A, B, D, E, F, G and Ar are as defined herein, and pharmaceutically acceptable salts thereof, useful in the prevention and treatment of hepatitis C infections.
本发明涉及公式(I)的化合物,其中R1,R2,A,B,D,E,F,G和Ar如本文所定义,并且其在药学上可接受的盐,在预防和治疗丙型肝炎感染方面非常有用。